Amneal Approval Leads Lannett To Job Losses

US Firm Will Consolidate R&D Operation

Around 80 more jobs are to go at Lannett, as the company reels from rival Amneal bagging US Food and Drug Administration approval for the company’s top seller.

Document
Another 80 jobs are to go at Lannett to bring down costs • Source: Shutterstock

More from Strategy

More from Business